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evelopmental sympathetic neuron death is deter-
mined by functional interactions between the TrkA/
NGF receptor and the p75 neurotrophin receptor
(p75NTR). A key question is whether p75NTR promotes
apoptosis by directly inhibiting or modulating TrkA activity,
or by stimulating cell death independently of TrkA. Here
we provide evidence for the latter model. Speciﬁcally,
experiments presented here demonstrate that the presence
or absence of p75NTR does not alter Trk activity or NGF-
and NT-3–mediated downstream survival signaling in primary
D
 
neurons. Crosses of p75NTR
 
 
 
/
 
 
 
 and TrkA
 
 
 
/
 
 
 
 mice indicate
 
that the coincident absence of p75NTR substantially rescues
TrkA
 
 
 
/
 
 
 
 sympathetic neurons from developmental death in
vivo. Thus, p75NTR induces death regardless of the presence
or absence of TrkA expression. These data therefore support
a model where developing sympathetic neurons are “destined
to die” by an ongoing p75NTR-mediated apoptotic signal,
and one of the major ways that TrkA promotes neuronal
survival is by silencing this ongoing death signal.
 
Introduction
 
The neurotrophic factor hypothesis, as originally formulated
(Thoenen and Barde, 1980; Levi-Montalcini, 1987; Op-
penheim, 1991), postulates that developing neurons are
overproduced and they compete for limited quantities of
target-derived growth factors such as NGF, which they
need for survival. Recent studies of NGF-dependent sympa-
thetic neurons have provided molecular insights into this
process, and have shown that the TrkA/NGF receptor
(Cordon-Cardo et al., 1991; Kaplan et al., 1991a,b; Klein
et al., 1991) mediates the survival effects of NGF dur-
ing development, but that the p75 neurotrophin receptor
(p75NTR)* (Johnson et al., 1986; Radeke et al., 1987) is
also necessary for appropriate developmental sympathetic
neuron death (reviewed in Kaplan and Miller, 2000). In par-
ticular, studies of the sympathetic superior cervical ganglia
(SCG) in animals mutant in one of these two receptors have
shown that (a) TrkA
 
 
 
/
 
 
 
 sympathetic neurons die during the
late neonatal and early postnatal periods (Smeyne et al.,
1994; Fagan et al., 1996); (b) in p75NTR
 
 
 
/
 
 
 
 mice, sympa-
thetic neuron number does not decrease during naturally
occurring cell death, but instead there is a delayed loss of
neurons between P21 and adulthood (Bamji et al., 1998);
and (c) the apoptosis of cultured p75NTR
 
 
 
/
 
 
 
 sympathetic
neurons is delayed after NGF withdrawal (Bamji et al.,
1998). Together these studies support a model wherein
p75NTR has an essential role in ensuring rapid and appropriate
apoptosis of sympathetic neurons that do not sequester
adequate levels of target-derived NGF (Majdan and Miller,
1999).
Recent evidence suggests a second, related role for
p75NTR during this same developmental period. Specifi-
cally, crosses of p75NTR
 
 
 
/
 
 
 
 and NT-3
 
 
 
/
 
 
 
 animals indicate
that p75NTR is essential for sympathetic neurons to dis-
tinguish between “preferred” (NGF) and “nonpreferred”
(NT-3) survival ligands (Brennan et al., 1999); sympa-
thetic neurons only responded to NT-3 with survival in vivo
when p75NTR was absent. Potential clues into the mecha-
nism underlying this phenomena derive from biochemical
studies of cultured sympathetic neurons, which demon-
strated that NGF but not NT-3 supported neuronal survival
at equivalent levels of TrkA activation (Belliveau et al.,
1997). This latter finding suggests that p75NTR antago-
nizes NT-3–mediated survival downstream of TrkA.
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Together these findings indicate that developmental sym-
pathetic neuron death is determined by a functionally antag-
onistic interplay between the TrkA and p75NTR receptors.
However, defining this interplay has been difficult because
in some cell types, p75NTR can directly interact with TrkA
and modify its ability to bind neurotrophins (Hempstead et
al., 1991; Benedetti et al., 1993; Ip et al., 1993; Bibel et al.,
1999), whereas in other cells, including cultured sympa-
thetic neurons, p75NTR can directly signal apoptosis in a
Trk-independent fashion (Casaccia-Bonnefil et al., 1996;
Frade et al., 1996; Aloyz et al., 1998; Bamji et al., 1998;
Davey and Davies, 1998; Soilu-Hanninen et al., 1999).
Consideration of these findings has led to the proposal of
two, not necessarily exclusive, models to explain the role of
p75NTR during developmental neuron death. One model
proposes that p75NTR mediates its proapoptotic effects in-
directly by modulating TrkA function. In this model,
p75NTR would rapidly eliminate neurons that fail to obtain
sufficient NGF by “tuning-down” the suboptimal TrkA sur-
vival signals, and would also modulate the binding of neu-
rotrophins to TrkA, so that only NGF (and not NT-3)
would be used as a survival ligand. The second model de-
rives from the hypothesis that all developing cells are “des-
tined to die,” and survival factors ensure survival of only ap-
propriately differentiated/connected cells (Raff, 1998). In
this model, p75NTR would provide a direct death signal in-
dependent of Trk or Trk signaling, and sympathetic neurons
would be rescued from death only if NGF activated TrkA to
sufficient levels to silence this death signal. In this case, the
ability of NT-3 to act as a survival ligand would be deter-
mined by the relative level of NT3-mediated activation of
TrkA versus p75NTR (Belliveau et al., 1997).
In this paper, we have tested these two models biochemi-
cally and genetically, and provide evidence for the second
model. Specifically, in these experiments, the presence or ab-
sence of p75NTR did not alter Trk activation or down-
stream signaling in primary sympathetic neurons, and
crosses of p75NTR
 
 
 
/
 
 
 
 and TrkA
 
 
 
/
 
 
 
 mice demonstrated that
the coincident absence of p75NTR substantially rescued the
sympathetic neuron apoptosis observed in TrkA
 
 
 
/
 
 
 
 animals.
These data therefore indicate that p75NTR signals death in
the presence or absence of TrkA, and support a model of
naturally occurring cell death where p75NTR provides an
ongoing death signal. Optimal TrkA activation can suppress
this signal in neurons that successfully compete for adequate
levels of target-derived trophic support.
 
Results
 
The absence of p75NTR leads to reduced apoptosis of 
developing sympathetic neurons
 
We have previously reported (Bamji et al., 1998) that in
p75NTR
 
 
 
/
 
 
 
 mice, sympathetic neurons of the SCG do not
decrease in number from postnatal day (P)1 to P21, the nor-
mal period of naturally occurring cell death, but instead un-
dergo a delayed decrease in neuronal number by adulthood.
A number of developmental processes could account for this
perturbation: an increase in the proliferation of sympathetic
neuroblasts, a decrease in the level of neuronal apoptosis, or
an alteration in the cell fates adopted by precursor cells in
the ganglion. To distinguish between these possibilities, we
assessed apoptosis and proliferation in pT5NTR
 
 
 
/
 
 
 
 versus
wild-type SCG.
Initially, we performed TUNEL to measure the total
number of apoptotic cells within the sympathetic SCG
on P2. To perform this analysis, every fourth section was
collected, TdT-mediated dUTP-biotin nick end labeling
(TUNEL) was performed, the positive nuclei were counted,
and the number of positive profiles were multiplied by four
to determine the total number of apoptotic nuclei per gan-
glia. As predicted, many TUNEL-positive nuclei were de-
tected within the wild-type SCG; 1,472 
 
 
 
 60 per ganglion
(
 
n 
 
  
 
3). In contrast, the p75NTR
 
 
 
/
 
 
 
 SCG contained only
290 
 
 
 
 45 apoptotic profiles per ganglion (
 
n 
 
  
 
3), a statisti-
cally significant decrease of 
 
 
 
80% (Fig. 1, A and B).
We next measured proliferation in the P3 and P4
p75NTR
 
 
 
/
 
 
 
 versus p75NTR
 
 
 
/
 
 
 
 ganglia. To examine the
extent of ongoing cell division, p75NTR
 
 
 
/
 
 
 
 and
p75NTR
 
 
 
/
 
 
 
 pups were injected twice with 50 mg/kg
BrdU, which is incorporated into newly synthesized DNA
during the S phase of the cell cycle. 2 d later, SCGs were
removed and processed for anti-BrdU immunocytochemis-
try. Direct counts of fluorescently labeled cells with neu-
ronal morphology demonstrated no change in the number
of BrdU-positive neurons in p75NTR
 
 
 
/
 
 
 
 and p75NTR
 
 
 
/
 
 
 
ganglia (1.43 
 
 
 
 0.7%, 
 
n 
 
  
 
3 and 1.25 
 
 
 
 0.3%, 
 
n 
 
  
 
3, re-
spectively) (Fig. 1 C). Thus, in the absence of p75NTR,
apoptotic sympathetic neuron death is greatly decreased,
and neuroblast proliferation is unperturbed, resulting in a
Figure 1. The increase in sympathetic neuron number in the 
neonatal p75NTR
 /  SCG is due to reduced apoptosis, not 
increased proliferation. (A) Fluorescence photomicrographs of 
TUNEL analysis of representative sections through the P2 SCG of 
p75NTR
 /  and p75NTR
 /  animals. (B) Quantitation of TUNEL 
analysis similar to that seen in A. Numbers represent the total mean 
number of apoptotic nuclei in the SCG of p75NTR
 /  (control) 
versus p75NTR
    (p75
 / ) animals. (**P   0.0005, n   3). (C) 
Percentage of BrdU-positive cells with neuronal morphology in the 
p75NTR
 /  (control) versus p75NTR
 /  (p75
 / ) SCG at P3 and P4 
(P   0.4, n   3 for each group). In both cases, error bars represent 
the standard error of the mean. 
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net increase in sympathetic neuron number relative to
wild-type ganglia.
 
Trk receptor levels, activation, and downstream 
signaling in p75NTR
 
 
 
/
 
 
 
 sympathetic neurons
 
Three potential explanations for the deficit in apoptosis ob-
served in p75NTR
 
 
 
/
 
 
 
 SCG are (1) Trk receptor levels, acti-
vation, and subsequent downstream survival signaling are
increased in the absence of p75NTR; (2) the absence of
p75NTR allows TrkA to respond more robustly to nonpre-
ferred ligands such as NT-3 (Benedetti et al., 1993; Ip et al.,
1993); and (3) p75NTR mediates a direct apoptotic signal-
ing cascade that is eliminated in its absence (Aloyz et al.,
1998). To examine the first two possibilities, we assayed Trk
receptor levels, activation, and downstream survival signal-
ing in p75NTR
 
 
 
/
 
 
 
 ganglia and cultured p75NTR
 
 
 
/
 
 
 
 neu-
rons. Initially, we examined levels of TrkA and TrkC in
p75NTR
 
 
 
/
 
 
 
 sympathetic ganglia at P7. SCG lysates were
run on SDS-PAGE, transferred to nitrocellulose, and
probed with an antibody specific to TrkA (RTA) (Clary et
al., 1994). Alternatively, lysates were precipitated with
WGA, which precipitates glycosylated proteins, and ana-
lyzed on Western blots with an antibody specific to the full-
length isoform of TrkC (Belliveau et al., 1997). This analy-
Figure 2. Levels of Trk receptors, Trk receptor activation, and downstream survival signaling in p75NTR
 /  SCG neurons. (A) Western blot 
analysis of equal amounts of protein from p75NTR
 /  versus p75NTR
 /  SCG at P7, probed for TrkA (RTA), tyrosine hydroxylase (TH) and 
ERK1. (B) Western blot analysis of lysates of P7 p75NTR
 /  versus p75NTR
 /  SCG that were precipitated with WGA and then probed with an 
antibody specific for TrkC or the intracellular region of p75NTR. Equal amounts of protein from the same lysates were also probed for ERK1. 
(C) Western blot analysis of equal amounts of protein from p75NTR
 /  versus p75NTR
 /  ganglia probed for p75NTR (p75), p53, or for total 
tubulin. (D) Western blot analysis of equal amounts of protein from cultured p75NTR
 /  versus p75NTR
 /  neonatal sympathetic neurons that 
were washed free of NGF, and then were induced with 0 or 50 ng/ml NGF for 10 min. Blots were probed with an antibody specific to phos-
photyrosine to detect tyrosine phosphorylated Trk (p-TYR), or with antibodies for the activated phosphorylated forms of Akt (p-AKT) or the 
ERKs (p-ERK), and then reprobed for TrkA (RTA), total ERKs (ERK), or p75NTR (p75). Note that in the ERK reprobe, a mobility shift is evident 
in the lysates from NGF-treated neurons, consistent with the increased levels of phosphoERK observed. (E and F) Western blot analysis of 
equal amounts of protein from cultured p75NTR
 /  versus p75NTR
 /  neonatal sympathetic neurons that were washed free of NGF and 
induced either with 50 ng/ml NGF for 1 h (E) or 20 ng/ml NT-3 for 10 min (F). Blots were probed with antibodies specific to phosphorylated 
Akt (p-AKT) or phosphorylated ERKs (p-ERK) and then reprobed with antibodies for total ERKs or for p75NTR (p75). (G) Western blot analysis 
for p75NTR in equal amounts of protein from p75NTR
 /  versus p75NTR
 /  ganglia at P7. The blot was reprobed for tubulin, scanned, and 
the ratio of p75NTR to tubulin was plotted on the accompanying bar graph. 
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sis revealed that levels of TrkA were slightly but consistently
decreased in the p75NTR
 
 
 
/
 
 
 
 SCG (Fig. 2 A), whereas TrkC
levels were constant (Fig. 2 B). In contrast, levels of ERK1
were unchanged (Figs. 2, A and B). Because full-length Trk
receptors are only expressed on sympathetic neurons and not
on nonneuronal cells in the ganglia, and neuronal number is
increased in the absence of p75NTR, these data indicate
that the decreased apoptosis in p75NTR
 
 
 
/
 
 
 
 SCG is not due
to an increase in Trk receptor levels.
We also compared a number of additional proteins in the
p75NTR
 
 
 
/
 
 
 
 and p75NTR
 
 
 
/
 
 
 
 ganglia at P7. We first exam-
ined levels of p75NTR itself, using an antibody to the intra-
cellular region that should recognize a splice variant still
present in Schwann cells of the exon III p75NTR
 
 
 
/
 
 
 
 ani-
mals examined in this study (Von Schack et al., 2001). No
p75NTR protein corresponding to this smaller variant was
detectable either in the p75NTR
 
 
 
/
 
 
 
 ganglia or in cultured
p75NTR
 
 
 
/
 
 
 
 sympathetic neurons (Fig. 2, B–F), indicating
that if this variant is expressed in developing sympathetic
neurons, its levels are very low. We next examined levels of
tyrosine hydroxylase and tubulin, two proteins associated
with sympathetic neuron phenotype. Western blot analysis
revealed that levels of both proteins were similar in
p75NTR
 
 
 
/
 
 
 
 and p75NTR
 
 
 
/
 
 
 
 ganglia (Fig. 2, A and C). Fi-
nally, we examined levels of p53, an apoptotic protein in
neurons (Slack et al., 1996) whose levels are increased by
p75NTR signaling in sympathetic neurons (Aloyz et al.,
1998). Western blot analysis revealed that, as would be pre-
dicted if p75NTR activation leads to increased levels of p53
during naturally occurring neuronal death, levels of p53 are
somewhat decreased in the p75NTR
 
 
 
/
 
 
 
 ganglia (Fig. 2 C).
Because examination of the p75NTR
 
 
 
/
 
 
 
 ganglia indicated
that the enhanced neuronal survival was not due simply to in-
creased levels of TrkA or TrkC, we next determined whether
Trk receptor activation and downstream survival signaling
were increased in the absence of p75NTR. Previous work has
demonstrated two survival pathways downstream of TrkA in
sympathetic neurons, the PI 3-kinase–Akt pathway and the
Mek–ERK pathway (for review see Kaplan and Miller, 2000).
We therefore cultured sympathetic neurons from p75NTR
 
 
 
/
 
 
 
and p75NTR
 
 
 
/
 
 
 
 SCG in 50 ng/ml NGF for 5 d, switched
them into 0 or 50 ng/ml NGF, and then assayed activation of
Trk and/or of these two survival pathways. Western blot anal-
ysis of sympathetic neurons induced for 10 min with 50 ng/
ml NGF revealed that Trk receptor activation was similar in
p75NTR
 
 
 
/
 
 
 
 and p75NTR
 
 
 
/
 
 
 
 neurons (Fig. 2 D). Moreover,
Western blots probed with antibodies to the activated, phos-
phorylated forms of Akt or the ERKs indicated that activation
of both of these pathways was similar in the presence or ab-
sence of p75NTR (Fig. 2 D). We performed similar studies
after 1 h of stimulation with 50 ng/ml NGF to ask whether
the kinetics of survival pathway activation were altered by the
presence or absence of p75NTR. Western blot analysis re-
vealed that even after 1 h, levels of activation of Akt and the
ERKs were similar in p75NTR
 /  and p75NTR
 /  neurons
(Fig. 2 E). Thus, TrkA activation and downstream survival
signaling in response to NGF were not enhanced in the ab-
sence of p75NTR.
We then examined Trk-mediated survival signaling in re-
sponse to NT-3. p75NTR
 /  sympathetic neurons have
previously been demonstrated to show enhanced survival in
response to NT-3 both in culture (Lee et al., 1994b) and in
vivo (Brennan et al., 1999). This increased NT-3–mediated
survival could be due to either (a) enhanced TrkA activation
and survival signaling in response to nonpreferred ligands
such as NT-3 in the absence of p75NTR or (b) the absence
of an antagonistic death signal resulting from NT-3 binding
to p75NTR. To distinguish between these two possibilities,
p75NTR
 /  and p75NTR
 /  neurons were cultured in
NGF for 5 d, washed free of neurotrophin, and exposed to
20 ng/ml NT-3 for 10 min. We have previously demon-
strated that 20 ng/ml NT-3 is sufficient to cause low levels
of TrkA receptor activation in sympathetic neurons (Bel-
liveau et al., 1997). Neurons were lysed and Western blots
of the lysates were probed with antibodies to phospho-Akt
or phospho-ERK, and reprobed for total ERK protein. This
analysis (Fig. 2 F) revealed that NT-3 caused a similar in-
duction in levels of phospho-Akt and phospho-ERK in
Figure 3. Cultured p75NTR
 /  neurons show enhanced survival 
in the absence of all Trk signaling. (A) Percentage survival of mouse 
sympathetic neurons switched for 72 h into varying concentrations 
of K252A in the presence or absence of 10 ng/ml NGF. Results are 
normalized so that the number of neurons at the time of NGF with-
drawal is 100%. Each point represents the values pooled from two 
to four independent experiments, each repeated in triplicate. Error 
bars represent the standard error of the mean. (B) Percentage 
survival of p75NTR
 /  versus p75NTR
 /  (wild-type) neurons at 
various time points after a switch into 0 ng/ml NGF plus or minus 
200 nM K252A. Results represent the mean   standard error of 
combined data from four separate experiments, each performed 
in triplicate.TrkA and p75NTR in neuronal survival in vivo | Majdan et al. 1279
p75NTR
 /  and p75NTR
 /  neurons, suggesting that the
observed increase in NT-3–mediated survival is not likely
due to enhanced Trk survival signaling, but is instead due to
the absence of an antagonistic p75NTR-mediated death cas-
cade in the knockout neurons.
Cultured p75NTR
 /  neurons show enhanced survival 
in the absence of all Trk signaling
Together, these data suggest that the enhanced survival ob-
served in p75NTR
 /  neurons is not due to enhanced Trk
signaling. However, to formally rule out this possibility, we
cultured p75NTR
 /  neurons and asked whether they
showed enhanced survival in the presence of K252a, a phar-
macological agent that inhibits all Trk receptor signaling
(Tapley et al., 1992).
Initially, we performed experiments to ensure that
K252A was capable of blocking Trk-mediated survival in
mouse neurons in the presence of exogenous NGF. We
have previously performed similar studies with rat sym-
pathetic neurons, and have demonstrated that 200 nM
K252A was sufficient to completely eliminate NGF-medi-
ated TrkA activation and block NGF-mediated survival
(Vaillant et al., 1999). To perform these experiments,
wild-type mouse sympathetic neurons were established in
50 ng/ml NGF for 5 d, and were then switched into 10 ng/
ml NGF in the presence of 10–200 nM K252A. Fields of
phase-bright neurons were then counted immediately after
the switch, and at 24 h intervals thereafter. This analysis
(Fig. 3 A) revealed that in the presence of 10 ng/ml NGF,
K252A decreased neuronal survival in a concentration-
dependent fashion over 72 h, with the maximal effect ap-
parent at 50–200 nM K252A: in 10 nM K252A, 45   8%
of neurons were still alive at 72 h, in 20 nM, 33   4%
were alive, whereas with 100 nM, only 14   9% were still
alive. We then performed similar studies where neurons
were withdrawn from NGF, and various concentrations of
K252A were added for 72 h to ensure that all Trk-medi-
ated survival signals were eliminated (Fig. 3 A). This analy-
sis confirmed that the addition of 50 or 200 nM K252A
eliminated any residual survival signaling that was due to
small amounts of NGF present in the cultures after the
washout period. Specifically, in 0 NGF 35   6% of neurons
were still alive, whereas in 50 and 200 nM K252A, 20  
6% and 18   3% were still alive, respectively.
We then analyzed the survival of p75NTR
 /  versus
p75NTR
 /  neurons after NGF withdrawal with and with-
out 200 nM K252A to eliminate all Trk-mediated survival
signaling. As previously reported (Bamji et al., 1998), com-
bined results of four independent experiments (each per-
formed in triplicate) revealed that p75NTR
 /  neurons died
significantly more slowly in the absence of NGF (Fig. 3 B).
Specifically, 24 h after NGF withdrawal, 94   1% of
p75NTR
 /  neurons were still alive, compared with 84  
6% of wild-type neurons (P   0.07). By 48 h, 75   7% of
p75NTR
 /  neurons were still alive, compared with 56  
8% of control neurons (P   0.06). By 72 h, 56   6% of
p75NTR
 /  neurons were alive, versus 35   6% of controls
(P   0.05). Interestingly, inhibition of Trk signaling with
K252A significantly decreased the baseline survival observed
with the wild-type neurons (P   0.05 at 72 h), whereas it
had no significant effect on the survival of p75NTR
 /  neu-
rons. Specifically, 24 h after NGF withdrawal, 95   1% of
p75NTR
 /  neurons were still alive, compared with 88  
2% of controls (P     0.05), and by 48 h 72   3% of
p75NTR
 /  neurons were alive, versus 50   6% of the
wild-type neurons (P   0.05). By 72 h, 50   5% of the
p75NTR
 /  neurons were still alive, versus 23   3% of
the wild type (P   0.005). Thus, the absence of p75NTR
prevents sympathetic neurons from undergoing appropriate
apoptosis after NGF withdrawal, even when all Trk signal-
ing is inhibited.
The coincident absence of p75NTR significantly 
rescues TrkA
 /  sympathetic neuron apoptosis in vivo
Although the data presented here on p75NTR
 /  sym-
pathetic neurons strongly support the hypothesis that
p75NTR causes sympathetic neuron apoptosis via a Trk-
independent mechanism, it is still possible that, in vivo,
p75NTR might function by directly modulating TrkA func-
tion. To distinguish between a Trk-dependent versus Trk-
independent action of p75NTR in vivo, we crossed the
p75NTR
 /  and TrkA
 /  animals; sympathetic neurons
undergo a rapid apoptotic death in TrkA
    animals as a
consequence of the lack of Trk-mediated survival signals
(Smeyne et al., 1994; Fagan et al., 1996). If p75NTR medi-
ates neuronal apoptosis by modulating TrkA and/or a TrkA-
dependent signaling cascade, then the absence of p75NTR
should have no effect on the TrkA
 /  phenotype. If, in con-
trast, p75NTR mediates neuronal apoptosis in a Trk-inde-
pendent fashion, then the severe neuronal loss seen in
TrkA
 /  SCG would be at least partially rescued in the ab-
sence of p75NTR.
To perform these studies, we initially confirmed the
p75NTR
 /  phenotype in the mixed C129/C57BL6 back-
ground that resulted from these crosses. TrkA
 /  and
Figure 4. Sympathetic neuron number is increased in the 
developing C129/C57Bl6 SCG as an inverse function of p75NTR 
gene dosage. Sympathetic neuron number in the SCG of p75NTR
 / , 
p75NTR
 / , and p75NTR
 /  animals at ages P1–P3 and P4–P6.
Results represent mean   standard error (n   3–7 for each genotype). 
At P1–P3, p75NTR
 /  and p75NTR
 /  SCG numbers are significantly 
different (*P   0.05), and at P4–P6, p75NTR
 /  neuron counts are 
significantly different from the p75NTR
 /  and p75NTR
 /  counts 
(*P   0.05 for both groups). For comparison, neuronal numbers 
from the P4 SCG of p75NTR
 /  and p75NTR
 /  C129 animals are 
shown (Bamji et al., 1998).1280 The Journal of Cell Biology | Volume 155, Number 7, 2001
p75NTR
 /  animals were crossed, and then their TrkA
 / ,
p75NTR
 /  progeny were bred to produce animals for
analysis. The SCGs were analyzed from the resultant
TrkA
 / , p75NTR
 / , p75NTR
 / , and p75NTR
 /  ani-
mals; ganglia were grouped by age, P1–P3 and P4–P6.
This analysis revealed an increase in the numbers of neu-
rons in the p75NTR
 /  versus p75NTR
 /  SCG at both
ages (P1–P3: 21,425   1,324, n   3 versus 16,390  
1,003, n   5, P   0.05; P4–P6: 27,221   3,570, n   6
versus 18,211   1,401, n   4, P   0.05) (Fig. 4), a phe-
notype similar to that observed in the C129 background
(Bamji et al., 1998).
Interestingly, an intermediate neuron number was ob-
served in the p75NTR
 /  SCG at both P1–P3 (18,606  
787, n   3) and P4–P6 (21,684   1,114, n   7) (Fig. 4),
suggesting that p75NTR levels are a key determinant of
sympathetic neuron survival. To confirm that p75NTR lev-
els were actually regulated as a function of gene dosage, as
these results suggest, we performed Western blot analysis in
the SCG of p75NTR
 /  and p75NTR
 /  animals at P7
(Fig. 2 G). This analysis revealed that p75NTR levels were
lower in the p75NTR
 /  animals, correlating with the ob-
served increase in neuronal survival.
We then characterized neuronal numbers in the SCG of
the p75NTR
 / , TrkA
 / , TrkA
 / , and TrkA
 /  animals
over this same time frame. This analysis revealed that, as pre-
viously reported (Fagan et al., 1996), there was a dramatic
decrease in the number of SCG neurons at P1–P3 in
the TrkA
 /  animals relative to their TrkA
 /  littermates
(6,108   411, n   3 versus 16,390   1,003, n   5). By
P4–P6, the neuronal loss in the TrkA
 /  SCGs was even
more substantial (3,557   724, n   3 versus 18,211  
1,401, n   4) (Fig. 5 A). These numbers represent a 63 and
80% decrease in neuronal number in the TrkA
 /  ganglia at
P1–P3 and P4–P6, respectively.
Interestingly, quantitation of sympathetic neurons in the
TrkA
 /  SCG revealed no significant difference between
numbers in TrkA
 /  and TrkA
 /  ganglia at these two time
points (P1–P3: 15,176   796, n   6; P4–P6: 19,777  
1880, n   3 for the TrkA
 /  SCG) (Fig. 5 A), although
Western blot analysis indicated that levels of TrkA were re-
duced in the TrkA heterozygotes (Fig. 5 B). This same anal-
ysis revealed that levels of TrkC were similar in the TrkA
 / 
and TrkA
 /  SCG (Fig. 5 B), indicating that TrkC was not
compensating for the lower levels of TrkA in these ganglia.
Thus, somewhat surprisingly, levels of TrkA are not rate-
limiting for survival at this age, whereas relatively small (i.e.,
twofold) differences in levels of p75NTR significantly affect
the level of neuronal survival.
Finally, we determined whether the absence of p75NTR
was able to rescue the dramatic loss of sympathetic neurons
observed in the TrkA
 /  SCG. At P1–P3, the concomi-
tant absence of p75NTR almost completely rescued sympa-
thetic neuron numbers in the TrkA
 / , p75NTR
 /  SCG;
13,665   730 neurons (n   3) versus 16,390   1,003 neu-
rons (n   5) in the TrkA
 / , p75NTR
 /  SCG (Fig. 6 A).
Moreover, at this age, even the loss of one p75NTR allele
was enough to significantly increase neuronal survival; the
TrkA
 / , p75NTR
 /  SCG contained 11,000 neurons,
whereas the TrkA
 / , p75NTR
 /  ganglia contained only
6,108   411 neurons. A rescue was also observed at P4–P6.
The magnitude was, however, lower than that seen at P1–
P3; 9,861   622 neurons (n   5) versus 3,557   724 neu-
rons (n   3) in the TrkA
 / , p75NTR
 /  SCG (Fig. 6 A).
Similarly, a rescue was still observed in the TrkA
 / ,
p75NTR
 /  ganglia at P4–P6, although this was of a lesser
magnitude than that observed in the p75NTR
 /  SCG.
Thus, independent signaling via p75NTR represents a ma-
jor default death pathway for developing sympathetic neu-
rons.
In spite of the increase in neuron number, double mu-
tant animals were not healthier than TrkA
 /  animals,
and most died within the first three postnatal days. More-
over, cresyl violet–stained sections of P4 wild-type and
TrkA
 / , p75NTR
 /  SCGs showed that the rescued cells
were much smaller than their wild-type counterparts, a
phenotype similar to that previously reported for sympa-
thetic neurons lacking other components of the cell death
machinery, such as Bax
 /  cells (Deckwerth et al., 1996).
To ensure that these smaller cells were in fact neurons, we
immunostained sections from P2 TrkA
 / , p75NTR
 / 
SCGs with an antibody for neuron-specific  III-tubulin,
and then Nissl-stained the alternate sections (Fig. 7). This
analysis revealed that all of the smaller neuronal cells ex-
pressed   III-tubulin, and that the numbers of neurons
obtained by counting the immunostained versus Nissl-
Figure 5. Analysis of sympathetic neuron number in TrkA
 / , 
TrkA
 / , and TrkA
 /  SCG. (A) Sympathetic neuron number in the 
SCG of TrkA
 / , TrkA
 / , and TrkA
 /  animals at ages P1–P3 and 
P4–P6 in the C129/C57BL6 background. Results represent mean   
standard error (n   3–5 for each genotype). At both ages, TrkA
 /  
neuron number is greatly decreased (**P   0.005), but there is no 
significant difference in the TrkA
 /  ganglia. (B) Western blot analysis 
of equal amounts of protein from the TrkA
 /  and TrkA
 /  SCG at 
P10. Blots were probed for TrkA, TrkC, and tubulin.TrkA and p75NTR in neuronal survival in vivo | Majdan et al. 1281
stained sections were similar: in two different p75NTR
 / ,
TrkA
 /  SCGs, 790 and 1032 cresyl violet–stained neu-
rons were present in representative sections, and 930 and
808   III tubulin-positive cells were present in the ad-
jacent sections, respectively. We also immunostained al-
ternate sections from the same animals for tyrosine hy-
droxylase (Fig. 7). Whereas there was significantly more
variability in tyrosine hydroxylase levels from cell to cell,
likely as a consequence of the fact that tyrosine hydroxyl-
ase levels are highly upregulated by Trk signaling, this
analysis confirmed that the small,  III-tubulin–positive
cells were sympathetic neurons (Fig. 7). Thus, although
the absence of p75NTR significantly rescued and/or de-
layed the cell death that occurs in the absence of TrkA sig-
naling, it was unable to rescue other TrkA-dependent
phenotypes, such as cell body hypertrophy and, presum-
ably, target innervation.
Discussion
The results described in this paper indicate that p75NTR
provides an apoptotic signal for developing sympathetic
neurons in the presence or absence of TrkA, and one of the
major ways that TrkA supports neuronal survival is by sup-
pressing this death signal. Specifically, these results support
five major conclusions. First, studies on the p75NTR
 / 
SCG indicate that the increased sympathetic neuron num-
ber previously reported (Bamji et al., 1998) is due to a dra-
matic deficit in neuronal apoptosis, and not to an increase in
neuroblast proliferation. Second, biochemical studies dem-
onstrate that there is no increase in TrkA or TrkC levels or
in Trk receptor activation in response to NGF in p75NTR
 / 
sympathetic neurons. Third, downstream NGF or NT-3–
mediated survival signaling is similar in p75NTR
 /  and
p75NTR
 /  sympathetic neurons. Fourth, pharmacological
studies demonstrate that p75NTR
 /  sympathetic neurons
are deficient in apoptosis after NGF withdrawal, even when
all Trk signaling is inhibited. Fifth, crosses of the p75NTR
 / 
and TrkA
 /  animals demonstrate that the loss of sympa-
thetic neurons seen in neonatal TrkA
 /  animals is substan-
tially rescued by the coincident absence of p75NTR.
Together, these data support a model of naturally occur-
ring neuronal death where p75NTR provides an ongoing
apoptotic signal that is suppressed by optimal TrkA activa-
tion in those neurons that successfully compete for NGF to
survive. These data also strongly argue that p75NTR does
not mediate its proapoptotic effects by modulating TrkA
and/or TrkA signaling cascades. Instead, these findings indi-
cate that p75NTR directly signals apoptosis in sympathetic
neurons in a TrkA-independent fashion. What is the biolog-
ical rationale for such a mechanism? It is likely that
p75NTR provides a molecular mechanism for ensuring
Figure 6. The absence of p75NTR rescues the sympathetic neuron 
apoptosis observed in the neonatal TrkA
 /  SCG. (A) Sympathetic 
neuron number in TrkA
 / , p75NTR
 / , p75NTR
 / , and p75NTR
 /  
SCG at P1–P3 and P4–P6. For comparison, TrkA
 / , p75NTR
 /  
(WT) SCG counts are also shown. Results represent mean   standard 
error (n   3–5 for each genotype). In the absence of TrkA, the 
number of neurons is increased in the p75NTR
 /  versus p75NTR
 /  
SCG at both P1–P3 (**P   0.0005) and P4–P6 (**P   0.001). In 
addition, at both developmental ages, the number of neurons in 
p75NTR
 /  SCG is significantly greater than in p75NTR
 /  SCG 
(*P   0.05 for both groups). (B) Photomicrographs of cresyl violet–
stained sections showing the morphology of SCG sympathetic 
neurons in p75NTR
 / , TrkA
 /  (left) and p75NTR
 / , TrkA
 /  (right) 
mice at P4. Arrows indicate sympathetic neurons.
Figure 7. p75NTR
 / , TrkA
 /  sympathetic neurons express 
neuron-specific  III-tubulin and tyrosine hydroxylase. Photomicro-
graphs of alternate sections taken from a p75NTR
 / , TrkA
 /  
ganglia and then either Nissl-stained or immunostained for the 
neuron-specific protein  III-tubulin or for tyrosine hydroxylase (TH). 
The upper panels are low-power micrographs of entire sections, and 
the bottom panels are high-power micrographs showing stained 
neurons (arrows).1282 The Journal of Cell Biology | Volume 155, Number 7, 2001
rapid and active apoptosis when a neuron is unsuccessful in
competing for adequate amounts of the appropriate neu-
rotrophin. If a sympathetic neuron reaches the appropriate
target and sequesters NGF, TrkA is robustly activated and
this activation silences any ongoing apoptotic signal deriving
from p75NTR (Bamji et al., 1998; Yoon et al., 1998; Maz-
zoni et al., 1999). Conversely, when a neuron is late arriving
and/or reaches an inappropriate target, TrkA is only weakly
(if at all) activated as a consequence of the lack of NGF, and
an ongoing p75NTR-mediated death signal would cause the
rapid apoptotic elimination of that neuron, thereby ensuring
that the subsequent period of target innervation occurs ap-
propriately. The importance of this rapid neuronal elimina-
tion is emphasized by the finding that sympathetic neuron
target innervation is highly aberrant in p75NTR
 /  animals
(Lee et al., 1994a).
What if a developing sympathetic neuron encounters a
neurotrophin such as NT-3, which has the capacity to
weakly activate TrkA (Belliveau et al., 1997)? Recent evi-
dence indicates that the absence of p75NTR enhances the
ability of NT-3 to function as a sympathetic neuron survival
factor both in culture (Lee et al., 1994b) and, importantly,
in vivo (Brennan et al., 1999). How does p75NTR mediate
this activity? As shown here, NT-3 activates downstream
survival signaling in p75NTR
 /  and p75NTR
 /  neurons
to a similar extent, and coincident p75NTR activation does
not affect the levels of sympathetic neuron TrkA activation
(Aloyz et al., 1998; Bamji et al., 1998) Thus, it is likely that
p75NTR “selects” survival ligands by antagonistically signal-
ing neuronal apoptosis. Thus, a weak TrkA survival signal
deriving from NT-3 would normally be overridden by a
strong apoptotic signal deriving from p75NTR, but in the
absence of p75NTR, this weak TrkA signal would be suffi-
cient for survival. It is still possible that NT-3 binding to
p75NTR might, in some cellular contexts, dampen down-
stream TrkA signaling, as has been recently observed in Xe-
nopus oocyte experiments (Mischel et al., 2001). How-
ever, the data presented here argue that this is not the
major mechanism responsible for the enhanced survival of
p75NTR
 /  sympathetic neurons in response to NT-3 (Lee
et al., 1994b; Brennan et al., 1999).
Data presented here also support the conclusion that
p75NTR plays a major role in sympathetic neuron apoptosis
after NGF withdrawal both in culture and in vivo:
p75NTR
 /  sympathetic neurons are delayed in their apop-
tosis in the absence of all Trk receptor signaling, and the ab-
sence of p75NTR
 /  substantially rescues neonatal TrkA
 / 
sympathetic neurons in vivo. Although the deficit in apopto-
sis observed in vivo could be due to the absence of p75NTR
on ganglionic satellite cells, Schwann cells, and/or peripheral
targets, the deficit in apoptosis observed in culture must be
intrinsic to sympathetic neurons themselves, making it more
likely that the in vivo alterations are also cell autonomous.
These findings also predict that p75NTR signaling consti-
tutes a major component of the apoptotic signaling path-
ways activated after NGF withdrawal. Support for this idea
derives from our previous work on the p53 tumor suppres-
sor protein during sympathetic neuron apoptosis (Miller et
al., 2000). These studies showed that (a) p53 is essential for
sympathetic neuron apoptosis after both NGF withdrawal
and p75NTR activation (Aloyz et al., 1998); (b) when Trk-
mediated activation of the Ras pathway is inhibited, sympa-
thetic neurons die via a p53-mediated pathway (Mazzoni et
al., 1999); and (c) in the p53
 /  SCG, sympathetic neurons
show reduced apoptosis (Aloyz et al., 1998), although this
deficit is not of the same magnitude as that reported here
for the p75NTR
 /  SCG. Together these studies support
a model where p75NTR leads to the activation of a
p53-mediated apoptotic pathway, and TrkA signaling si-
lences this apoptotic pathway via activation of Ras (Kaplan
and Miller, 2000). Thus, when NGF is withdrawn, the
p75NTR-mediated death pathway is “unmasked,” a process
that substantially contributes to the subsequent neuronal
apoptosis. Interestingly, we show here that levels of p53 are
decreased in the developing p75NTR
 /  SCG, suggesting
that p75NTR may contribute to the activation of this same
apoptotic pathway in vivo.
Previous work on p75NTR
 /  sympathetic neurons in
culture have reached conclusions somewhat different from
those reported here. Davies et al. (1993), studying embry-
onic sympathetic neurons, reported that NGF supported
survival of p75NTR
 /  and p75NTR
 /  neurons equally
well. In contrast, Lee et al. (1994b) reported that acutely dis-
sociated sympathetic neurons from p75NTR
 /  P3 or P4
animals required slightly higher concentrations of NGF to
maintain full survival. These two studies differ from the cur-
rent study in two respects. First, the neurons cultured here
were derived from P1 animals. Second, and likely of more
importance, is the fact that both of the previous studies ex-
amined acutely dissociated sympathetic neurons. In the ex-
periments reported here, we established sympathetic neu-
rons for 5 d in NGF before NGF withdrawal to ensure that
we were studying healthy neurons that had not been recently
axotomized. In this regard, we have directly compared bio-
chemical parameters in acutely dissociated versus established
sympathetic neuron cultures, and have demonstrated that
these two neuron populations differ significantly with re-
spect to p75NTR levels and stress pathway induction (un-
published data). We therefore feel it is likely that any dif-
ferences from these previous studies are likely due to
differences in culture models.
What are the ligands for p75NTR during developmental
sympathetic neuron death or in culture after NGF with-
drawal? In vivo, p75NTR is likely robustly activated by non-
TrkA-binding neurotrophins, such as brain-derived neu-
rotrophic factor (BDNF; Leibrock et al., 1989), that are
encountered in the target environment (Kohn et al., 1999)
and/or that are made by sympathetic neurons themselves
(Causing et al., 1997). In this regard, sympathetic neuron
number is increased in BDNF 
 /  animals (Bamji et al.,
1998), supporting the idea that BDNF is one endogenous
apoptotic ligand for p75NTR. Similarly, BDNF (Causing et
al., 1997) and NT-4 (unpublished data) are both made by
cultured sympathetic neurons and may contribute to an au-
tocrine p75NTR–driven apoptotic loop after NGF with-
drawal. However, it is also formally possible that, as previ-
ously proposed (Bredesen et al., 1998), p75NTR may signal
in an unliganded fashion in certain situations, or that it
might bind to an as yet unidentified autocrine ligand to pro-
vide an ongoing receptor-mediated apoptotic signal.TrkA and p75NTR in neuronal survival in vivo | Majdan et al. 1283
Although all of these data support the idea that p75NTR
plays a major role in regulating developmental sympathetic
neuron apoptosis, several observations reported here indicate
that p75NTR-independent pathways are also very impor-
tant. In particular, our work shows that sympathetic neuron
rescue is substantial but not complete in the p75NTR
 / ,
TrkA
 /  mice at birth, and sympathetic neuron number de-
creases in these double knockout animals between birth and
P4–P6, suggesting that death is still ongoing in vivo, but at a
reduced rate. Moreover, p75NTR
 /  sympathetic neurons
still die in culture, albeit more slowly, when NGF is with-
drawn or when Trk function is pharmacologically inhibited.
What might these p75NTR-independent pathways be? Pre-
vious work indicates that, after NGF withdrawal, sympa-
thetic neurons activate a number of components of the cell
cycle (Park et al., 1996, 1997), an activation that contributes
to neuronal apoptosis. This cell cycle pathway may well rep-
resent a p75NTR-independent pathway that is responsible
for the delayed apoptosis of p75NTR
 /  sympathetic neu-
rons. Such a model implies that TrkA would suppress this
pathway independent of its effects on p75NTR; TrkA is
known to lock PC12 cells out of the cell cycle (Burstein and
Greene, 1982), and a number of Trk family members are
thought to play key roles in regulating the progenitor to
postmitotic neuron transition (Verdi and Anderson, 1994;
Ghosh and Greenberg, 1995). Interestingly, cell cycle dereg-
ulation can lead to p53 activation (Sherr and Weber, 2000),
and it is therefore possible that p53 and/or other p53 family
members such as p63 (Yang et al., 1998) or p73 (Jost et al.,
1997; Kaghad et al., 1997; Pozniak et al., 2000) may play a
key role in integrating both p75NTR-dependent and -inde-
pendent apoptotic pathways in developing sympathetic neu-
rons.
Together, the data reported here support a model of natu-
rally occurring neuronal death where an ongoing, receptor-
mediated apoptotic signal destines cells to die, and where
one of the major roles of exogenous survival ligands is to si-
lence this ongoing apoptotic signal. In the case of sympa-
thetic neurons, p75NTR provides the death signal and TrkA
the survival signal. The emerging evidence of a similar inter-
play between death and survival receptors in other develop-
ing neurons (Raoul et al., 1999; Agerman et al., 2000) ar-
gues that such a mechanism may prove to be the rule rather
than the exception.
Materials and methods
Analysis of C129/C57BL6 mice
Mice homozygous for a targeted mutation in the p75NTR gene (Lee et al.,
1992; genetic background C129) and heterozygous for a targeted mutation
in the TrkA gene (Smeyne et al., 1994; genetic background C57BL6) were
obtained from Jackson ImmunoResearch Laboratories. Initially, p75NTR
 / 
animals were crossed with TrkA
 /  animals, their progeny were genotyped
using PCR, and the p75NTR
 / , TrkA
 /  animals (now in a mixed back-
ground) were bred. The progeny of these crosses were analyzed and/or
used for breeding to generate second generation progeny for analysis. No
differences were noted in phenotype or sympathetic neuron number in an-
imals that were first or second generation in the mixed C129/C57Bl6 back-
ground. For morphometric analyses, SCGs were removed and immersion
fixed in 4% paraformaldehyde in phosphate buffer for 1 h at 4 C. Ganglia
were cryoprotected in graded sucrose solutions, 7- m–thick sections were
serially cut on a cryostat, and every section was collected on chromium/
aluminum/gelatin–coated slides. Slides were stained with cresyl violet, and
morphometric analyses were performed with the Northern Eclipse com-
puter-based image analysis software (Empix Inc.) using a Sony XC-75CE
CCD video camera, as we have previously described (Aloyz et al., 1998;
Bamji et al., 1998; Pozniak et al., 2000). Neuronal numbers were deter-
mined by counting all neuronal profiles with nucleoli on every fourth sec-
tion and multiplying the obtained number by four, as per Coggeshall
(1984). This method does not correct for split nucleoli. Statistical results
were expressed as the mean   the standard error of the mean and were
tested for significance by a one-tailed Student’s t test.
Alternatively, alternate sections were immunostained for neuron-spe-
cific  III-tubulin or tyrosine hydroxylase. Sections were initially treated in
0.3% hydrogen peroxide in PBS, pH 7.4, for 30 min. They were then incu-
bated in 10% normal goat serum and 0.25% Triton X-100 in PBS for 30
min, and incubated for 24 h at room temperature in antibodies either for
neuron-specific  III-tubulin (1:2,000; RDI) or tyrosine hydroxylase
(1:1,000; Chemicon). Primary antibodies were diluted in PBS containing
3% normal goat serum and 0.25% Triton X-100. After a rinse in PBS, sec-
tions were incubated in the same solution containing biotinylated goat anti–
rabbit IgG (1:200; Jackson ImmunoResearch Laboratories) for 1 h at room
temperature. They were then rinsed, incubated in avidin–biotin complex
(Vector Laboratories) for 1 h at room temperature, and then rinsed again.
Sections were reacted with a solution containing 0.05% DAB tetrachloride,
0.04% nickel chloride, and 0.015% hydrogen peroxide in 0.1 M PBS. After
the DAB reaction, sections were rinsed, dehydrated through a graded series
of ethanols, coverslipped, and viewed under brightfield optics.
For TUNEL, ganglia were fixed for 30 min in 4% paraformaldehyde,
cryoprotected, sectioned, and collected as above. TUNEL was performed
immediately on every fourth section (in situ cell detection kit; Boehringer)
as per the manufacturer’s instructions, and as we have previously de-
scribed (Aloyz et al., 1998). For BrdU incorporation assays, P3 and P4
pups were injected intraperitoneally on two consecutive days with 50 mg/
kg BrdU. Sympathetic ganglia were processed as above, and anti-BrdU im-
munocytochemistry was performed. The number of BrdU-positive cells
was determined by direct counts of labeled cells with neuronal mor-
phology.
Primary neuronal cultures
Mass cultures from the SCG of P1 mice were cultured by a modification of
the method used for rat neurons. Specifically, ganglia were dissected and
triturated as for rat ganglia (Belliveau et al., 1997; Vaillant et al., 1999), ex-
cept that neurons were dissociated in the presence of Ultraculture media
(Biowhittaker, Inc.) instead of saline solution. Neurons were then plated on
collagen-coated 96-well culture dishes (Falcon Plastics) in Ultraculture
media containing 2 mM glutamine, 100 U/ml penicillin, 100  g/ml strep-
tomycin, 3% FBS (Life Technologies), and 50 ng/ml mouse 2.5 S NGF pre-
pared from mouse salivary gland (Cedarlane Labs, Ltd.). 3 d after plating,
neurons were fed with the same media containing 0.5% cytosine arabino-
side (Sigma-Aldrich).
For survival assays, after 5 d in culture, neurons were washed three
times with neurotrophin-free media for 2.5 h total. After the washout, neu-
rons were cultured with or without 10 ng/ml NGF plus or minus various
concentrations of K252A (Calbiochem-Novabiochem). The number of
phase-bright neurons with neurites in randomly selected, 5.3-mm
2 fields
was counted immediately after the NGF washout in all conditions, and
then recounted at 24-h intervals for 4 d. In every experiment, each condi-
tion was repeated in triplicate. In three of the four experiments analyzed,
p75NTR
 /  and p75NTR
 /  neurons were cultured at the same time in the
same 96-well plates to eliminate variability.
Western blot analysis
For Western blot analysis of SCGs and cultured neurons, ganglia or neu-
rons were lysed and analyzed as previously described (Aloyz et al., 1998;
Vaillant et al., 1999). Immunoprecipitations of total Trk protein and WGA
precipitations of TrkC were also performed as previously described (Bel-
liveau et al., 1997; Bamji et al., 1998). The antibodies used for these anal-
yses were anti-phosphotyrosine 4G10 (1:5,000; Upstate Biotechnology),
anti-pan Trk 203B (1:2,000; gift of D. Kaplan, Montreal Neurological Insti-
tute, McGill University, Montreal, Canada), anti-TrkA RTA (1:2,000; gift of
L. Reichardt, University of California San Francisco, San Francisco, CA),
anti-p75NTR (1:2,000; Promega), anti-erk 1 (1:5,000; Santa Cruz Biotech-
nology, Inc.), anti-tubulin (1:5,000; Oncogene Research Products), anti-
TrkC (gift of D. Kaplan), anti-phospho–MAPK (p-ERK, 1:5,000; Promega),
anti-phospho-Akt (1:1000; Cell Signaling Technology), and anti-tyrosine
hydroxylase (1:1000; Chemicon). Secondary antibodies were incubated
for 1.5 h at room temperature, and were used at a 1:10,000 for both the
goat anti–mouse HRP antibody and the goat anti–rabbit HRP antibody1284 The Journal of Cell Biology | Volume 155, Number 7, 2001
(both from Boehringer). Detection was performed using ECL (Amersham
Pharmacia Biotech) and XAR x-ray film (Eastman Kodak Co.)
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